Insider Transactions

What NRX Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Javitt Jonathan C	Chairman and Chief Scientist	Dec 17	Open-market buy · P	+40,000	$1.17	+$46.8K	84,634
Hurvitz Chaim	Director	Aug 30	Open-market buy · P	+70,000	$0.29	+$20.1K	570,000
Gorovitz Aaron	Director	Aug 30	Open-market buy · P	+35,000	$0.32	+$11.2K	105,000
Javitt Jonathan C	Chief Scientist	Aug 23	Open-market buy · P	+100,000	$0.33	+$33K	446,332
Javitt Jonathan C	Chief Scientist	Aug 22	Open-market buy · P	+200,000	$0.32	+$64.4K	346,332
Willard Stephen H	CHIEF EXECUTIVE OFFICER	Dec 16	Open-market buy · P	+50,000	$1.17	+$58.5K	50,000
Van Voorhees Seth	CHIEF FINANCIAL OFFICER	Dec 16	Open-market buy · P	+30,000	$1.10	+$33K	46,337
Javitt Jonathan C	Director	Dec 14	Gift · G	−300,000	—	—	14,468,329
Javitt Jonathan C	Director	Dec 07	Open-market sale · S	−400,000	$1.00	−$400K	12,899,997
Javitt Daniel C.	10% owner	Nov 30	Open-market sale · S	−8,441	$1.50	−$12.7K	9,634,793
Javitt Daniel C.	10% owner	Nov 29	Open-market sale · S	−13,730	$1.50	−$20.7K	9,643,234
Flynn Patrick John	Director	Nov 28	Open-market buy · P	+1,750	$1.25	+$2.19K	1,750
Flynn Patrick John	Director	Nov 28	Open-market buy · P	+2,500	$1.24	+$3.1K	40,209
Flynn Patrick John	Director	Nov 28	Open-market buy · P	+2,500	$1.25	+$3.13K	37,709
Flynn Patrick John	Director	Nov 28	Open-market buy · P	+2,500	$1.25	+$3.13K	40,209
Flynn Patrick John	Director	Nov 28	Open-market buy · P	+2,500	$1.25	+$3.13K	37,709
Van Voorhees Seth	CHIEF FINANCIAL OFFICER	Nov 25	Open-market buy · P	+7,021	$1.11	+$7.79K	16,337
Van Voorhees Seth	CHIEF FINANCIAL OFFICER	Nov 25	Open-market buy · P	+600	$1.10	+$660	9,316
Van Voorhees Seth	CHIEF FINANCIAL OFFICER	Nov 25	Open-market buy · P	+8,716	$1.12	+$9.76K	8,716
Hurvitz Chaim	Director	Nov 18	Open-market buy · P	+40,408	$1.10	+$44.4K	500,000

Page 1 of 4 · showing the 20 most recent Sign up free to view all 62 transactions and filter by insider →

Comments